Hide Board Information

Show Board Information

Sunday, July 27, 2025 12:52:36 PM

Love International Group, Inc. LOVV

Board Mod: Add me as mod

Asst Mods:

Last Post: 04/09/2025 4:23:37 AM

Board Marks: 1

Posts Today: 0

Board Views Today: 1

Love International Group, Inc. (OTCMRKTS: LOVV) Stock Message Board

Detailed Quote

Invalid Symbol: LOVV

1. LOVV Company Profile

    

2. LOVV Time & Sales

    

3. LOVV Recent News

    

4. LOVV Filings

    

5. LOVV Financials

    

6. LOVV Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1280	is this dead already chart looks weird	PowerPuncher	09/24/2023 11:50:10 AM
836	How can businesses effectively manage their data	b85000	03/30/2023 9:29:27 AM
804	Love International Group, Inc. (LOVV) is a	Albert364	03/23/2023 7:36:17 AM
754	CNI (Container Network Interface) is a standard	IT-level-99	03/01/2023 5:42:48 AM
602	A random fact about the company is that it often	AlexandroGomes	12/07/2022 3:42:02 PM
480	This stock is revoked. It's a spam board now.	Steel Reserve	10/02/2022 5:05:18 PM
392	Investing in Social Media Marketing: A Detailed	paultate	08/23/2022 3:28:09 AM

Newer

Recent Articles

• Steve Eisman's Take on Opendoor's Soaring Stock Price
• Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
• Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
• Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
• Exploring the Success of CBD Fair Guangzhou's 2025 Edition
• Economic Impact of Trump's Trade Deal: What Comes Next?
• Antengene Prepares for Major Presentation on ATG-022 at ESMO
• How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
• Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
• Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
• US and China Seek Trade Solutions Amid Tariff Tensions
• Introducing Automate's Push PRO: Revolutionary Shade Control
• Exciting Esports World Cup Promotion from JBO Thailand
• Harbour BioMed Unveils Strong Profit Predictions for Future Growth
• Ascletis Begins Significant Obesity Study with ASC30 Drug
• Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
• Perseus Mining's Operational Highlights and Financial Overview
• Shara Magomedov Shines at UFC Night with Epic Victory
• Investors Urged to Participate in Class Action Against Centene
• Exploring America’s Hidden Resource Potential and Technology
• Trump's New Tariff Deal with EU: Impacts and Insights
• Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
• Empowering Hims & Hers Health Shareholders: Your Legal Guide
• Public Sentiment on Trump's Tax Cuts: A Closer Look
• Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
• Easterly ROCMuni Fund Class Action: Investor Rights Explained
• Class Action Alert: RxSight Investors Take Action Against Losses
• Investors of iRobot Corporation Urged to Act Before Deadline
• Dustin Moskovitz Expands Asana Holdings with Major Purchase
• Navigating High-Stress Careers: Insights from Executives
• Banco Comercial Português Updates on Share Buy-Back Programme Activity
• Centene Corporation Faces Class Action Over Investor Losses
• Banco Comercial Português (BCP) Shares Buy-Back Program Update
• Insights into Gilead Sciences, Inc. and Recent Developments
• Legal Action Initiated Against Flywire Corporation's Officers
• Replimune Group Faces Legal Action Amid Stock Price Decline
• Investors Seek Clarity on Simulations Plus Financial Concerns
• Shocking Survey: How Much Would You Sacrifice For Wealth?
• Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
• Neuralink’s Recent Developments and Future Aspirations Explained
• Global AI Cooperation: China's Vision for the Future of Technology
• Investment Insights from Experts: Maximize Your $10,000 Now
• Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
• Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
• Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
• Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
• Investors Take Note: Class Actions Against Western Asset Management
• Mereo BioPharma Faces Scrutiny as Investigation Unfolds
• Centene Corporation Faces Class Action Lawsuit Amidst Losses
• Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations